Tazemetostat Expanded Access Program for Adults With Epithelioid Sarcoma

NCT04225429 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Epithelioid Sarcoma

Interventions

DRUG: Tazemetostat

Sponsor

Epizyme, Inc.